Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
4,692
Views
9
CrossRef citations to date
0
Altmetric
Review

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

Shashi Gujara Department of Pathology, Dalhousie University, Halifax, NS, Canada;b Department of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada;c Department of Biology, Dalhousie University, Halifax, NS, Canada;d Beatrice Hunter Cancer Research Institute, Halifax, NS, CanadaView further author information
,
Jonathan G. Pole Equipe 11 Labellisée Par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France;f Gustave Roussy Cancer Campus, Villejuif, France;g Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, FranceView further author information
,
Youra Kima Department of Pathology, Dalhousie University, Halifax, NS, CanadaView further author information
&
Guido Kroemere Equipe 11 Labellisée Par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Université de Paris, Sorbonne Université, Paris, France;f Gustave Roussy Cancer Campus, Villejuif, France;g Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;h Institut Universitaire de France, Paris, France;i Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;j Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China;k Department of Women’s and Children’s Health, Karolinska Institute, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9334-4405View further author information
ORCID Icon
Article: 1794424 | Received 28 Jun 2020, Accepted 06 Jul 2020, Published online: 16 Jul 2020

References

  • Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–4. doi:10.1172/JCI137244.
  • Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 26, 453–455 (2020).
  • Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020:217. doi:10.1084/jem.20200678.
  • Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G. Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies. Trends Immunol. 2018;39:209–221. doi:10.1016/j.it.2017.11.006.
  • Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489–1501.e15. doi:10.1016/j.cell.2020.05.015.
  • Pia L. SARS-CoV-2-reactive T cells in patients and healthy donors. Nat Rev Immunol. 2020;20:2–353. doi:10.1038/s41577-020-0333-2.
  • Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, van den Akker JPC, Molenkamp R, Koopmans MPG, van Gorp ECM, et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020;5:eabd2071. doi:10.1126/sciimmunol.abd2071.
  • Sharma P, Allison JP. Dissecting the mechanisms of immune checkpoint therapy. Nat Rev Immunol. 2020;20:75–76. doi:10.1038/s41577-020-0275-8.
  • Rosato PC, Wijeyesinghe S, Stolley JM, Nelson CE, Davis RL, Manlove LS, Pennell CA, Blazar BR, Chen CC, Geller MA, et al. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy. Nat. Commun. 2019;10:1–567. doi:10.1038/s41467-019-08534-1.
  • Millar DG, Ramjiawan RR, Kawaguchi K, Gupta N, Chen J, Zhang S, Nojiri T, Ho WW, Aoki S, Jung K, et al. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy. Nat. Biotechnol. 2020;38:420–425. doi:10.1038/s41587-019-0404-8.
  • Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, Jones L, Crough T, Dasari V, Klein K, et al. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014;74(13):3466–3476. doi:10.1158/0008-5472.CAN-14-0296.
  • Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, Gresik MV, Gee AP, Russell HV, Brenner MK, et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes. Blood. 2005;105(5):1898–1904. doi:10.1182/blood-2004-07-2975.
  • Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Mol Ther. 2007;15:651–659. doi:10.1038/sj.mt.6300108.
  • Pol J, Lévesque S, Workenhe S, Gujar S, Le Boeuf F, Clements D, Bell JC, Mossman KL, Fucikova J, Spisek R, et al. Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology. 2018;7. doi:10.1080/2162402X.2018.1503032.
  • Gujar S, Bell J, Diallo JS. SnapShot: cancer immunotherapy with oncolytic viruses. Cell. 2019;176:1240–1240.e1. doi:10.1016/j.cell.2019.01.051.
  • Borrie AE, Maleki Vareki S. T lymphocyte-based cancer immunotherapeutics. Int Rev Cell Mol Biol. 2018;341:201–276.
  • Galluzzi L, Chan TA, Kroemer G, Wolchok JD, Lopez-Soto A. The hallmarks of successful anticancer immunotherapy. Sci. Transl. Med. 2018;10:eaat7807. doi:10.1126/scitranslmed.aat7807.
  • Melero IP, Gato M, Shekarian T, Aznar A, Valsesia-Wittmann S, Caux C, Etxeberrria I, Teijeira A, Marabelle A. Repurposing infectious disease vaccines for intratumoral immunotherapy. J Immunother Cancer. 2020;8:e000443. doi:10.1136/jitc-000443.
  • Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368:1012–1015. doi:10.1126/science.abb7314.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.